NANOBIOTIX Presents at Key Conferences in March

Nanobiotix, a French biotechnology company, will participate in several investor conferences in March 2026. These events will take place mainly in the United States and will offer an opportunity for the company to present its innovations in cancer treatments.

On March 4, Nanobiotix will speak at the TD Cowen Health Care Conference in Boston. Laurent Levy, President, and Bart van Rhijn, Chief Financial Officer, will participate in open discussions. The UBS Biotech Summit and Jefferies Biotech on the Beach Summit, both located in Miami, will follow on March 9 and 10, respectively.

Nanobiotix will be participating in the Leerink's Global Healthcare Conference on March 11 in Miami. At each event, Nanobiotix will highlight its advancements in cancer treatment using nanoparticles.